Coherus NSCLC treatment toripalimab meets primary endpoint in late-stage trial
March 15 2022 - 9:13AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Coherus BioSciences (NASDAQ:CHRS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Coherus BioSciences (NASDAQ:CHRS)
Historical Stock Chart
From Apr 2023 to Apr 2024